Medicinal Cannabis Reduces or Ends Seizures in Children with Severe, Drug-resistant Epilepsy

drug-resistant epilepsy

Medicinal cannabis oil containing both cannabidiol (CBD) and a small amount of THC can reduce or end seizures in children with severe, drug-resistant epilepsy, a study by the University of Saskatchewan (USask), Canada has found. Children with severe drug-resistant epilepsy also experienced improvements in their quality of life after takingRead …

Read moreMedicinal Cannabis Reduces or Ends Seizures in Children with Severe, Drug-resistant Epilepsy

Could the Endocannabinoid System Offer a New Treatment Target for Obsessive Compulsive Disorder?

CBD for Obsessive Compulsive Disorder

The disabling condition of obsessive-compulsive disorder (OCD) affects about 2–3% of people worldwide. Evidence suggests that abnormalities in cortico-striatal-thalamic-cortical circuitry and specific gene variants contribute to the pathogenesis of the disorder. This latest study, published in Cannabis and Cannabinoid Research, suggests that the endocannabinoid system (ECS) plays a role in OCD symptomsRead …

Read moreCould the Endocannabinoid System Offer a New Treatment Target for Obsessive Compulsive Disorder?

International Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal

Cannabis and Cannabinoid Research

New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is extremely excited to announce that the International Cannabinoid Research Society (ICRS) has named CCR its Official Journal. The ICRS is a foremost international society spearheading scientific research in all fields of cannabinoids, ranging from biochemical, chemical, and physiological studiesRead …

Read moreInternational Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal

Four Articles: Cannabis and Cannabinoid Use in Palliative Care, Open Access until May 6, 2019

Patients are aware that medical cannabis and cannabinoid derivatives are available to treat pain and symptoms. However, the medical literature to guide palliative medicine physicians in recommending cannabis and cannabinoid use is not yet well developed. The Journal of Palliative Care, David Casarett, MD, Guest Editor and Chief of Palliative CareRead …

Read moreFour Articles: Cannabis and Cannabinoid Use in Palliative Care, Open Access until May 6, 2019

Interaction of Neurotransmitters and Neurochemicals with Lymphocytes, including the Endocannabinoid System

Neurotransmitters and neurochemicals

Neurotransmitters and neurochemicals can act on lymphocytes by binding to receptors expressed by lymphocytes. This review describes lymphocyte expression of receptors for a selection of neurotransmitters and neurochemicals, the anatomical locations where lymphocytes can interact with neurotransmitters, and the effects of the neurotransmitters on lymphocyte function. Implications for health andRead …

Read moreInteraction of Neurotransmitters and Neurochemicals with Lymphocytes, including the Endocannabinoid System

Safety and Efficacy of Medical Cannabis in Elderly Patients: A Retrospective Review in a Neurological Outpatient Setting

Medical Cannabis in Elderly Patients

As more states legalize medical cannabis, clinicians are seeking more information on how it may affect elderly populations for chronic conditions associated with aging. In this study, published in the journal Neurology, researchers evaluated medical cannabis’ (MC) efficacy and adverse effects (AE) in patients 75 years of age or older.Read …

Read moreSafety and Efficacy of Medical Cannabis in Elderly Patients: A Retrospective Review in a Neurological Outpatient Setting

FDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products

Legal Cannabis

 Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L.) and itsRead …

Read moreFDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products

How Do Cannabinoid Receptors Affect Motivation to Eat or Exercise?

Physical inactivity is a common factor in lifestyle diseases – and one that is often linked to the excessive consumption of fatty and/or sugary foods. The opposite scenario of excessive physical activity at the expense of caloric intake can also be harmful, as cases of anorexia nervosa illustrate. These scenariosRead …

Read moreHow Do Cannabinoid Receptors Affect Motivation to Eat or Exercise?